Publications

J Blander M, Medzhitov R.  2006.  Toll-dependent selection of microbial antigens for presentation by dendritic cells.. Nature. 440(7085):808-12.

Ravichandran V, Shameer Z, Kemel Y, Walsh M, Cadoo K, Lipkin S, Mandelker D, Zhang L, Stadler Z, Robson M et al..  2019.  Toward automation of germline variant curation in clinical cancer genetics.. Genet Med. 21(9):2116-2125.

Sonnenberg GF.  2016.  Transcriptionally defining ILC heterogeneity in humans.. Nat Immunol. 17(4):351-2.

Lima S, Gogokhia L, Viladomiu M, Chou L, Putzel G, Jin W, Pires S, Guo C-J, Gerardin Y, Crawford CV et al..  2021.  Transferable IgA-coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.. Gastroenterology.

Withers DR, Hepworth MR, Wang X, Mackley EC, Halford EE, Dutton EE, Marriott CL, Brucklacher-Waldert V, Veldhoen M, Kelsen J et al..  2016.  Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells.. Nat Med. 22(3):319-23.

Nice TJ, Osborne LC, Tomov VT, Artis D, E Wherry J, Virgin HW.  2016.  Type I Interferon Receptor Deficiency in Dendritic Cells Facilitates Systemic Murine Norovirus Persistence Despite Enhanced Adaptive Immunity.. PLoS Pathog. 12(6):e1005684.

Malik F, Scherl E, Weber U, Carrino JA, Epsten M, Wichuk S, Pedersen SJ, Paschke J, Schwartzman S, Kroeber G et al..  2021.  Utility of magnetic resonance imaging in Crohn's associated sacroiliitis: A cross-sectional study.. Int J Rheum Dis.

Pan Y, Ahmed W, Mahtani P, Wong R, Longman R, Lukin DJeremy, Scherl EJ, Battat R.  2022.  Utility of Therapeutic Drug Monitoring for Tumor Necrosis Factor Antagonists and Ustekinumab in Postoperative Crohn's Disease.. Inflamm Bowel Dis. 28(12):1865-1871.

Tsou AM, Liu Z, Cai T, Zhu J.  2011.  The VarS/VarA two-component system modulates the activity of the Vibrio cholerae quorum-sensing transcriptional regulator HapR.. Microbiology (Reading). 157(Pt 6):1620-1628.

Hirten R, Longman RS, Bosworth BP, Steinlauf A, Scherl E.  2015.  Vedolizumab and Infliximab Combination Therapy in the Treatment of Crohn's Disease.. Am J Gastroenterol. 110(12):1737-8.

Liu Z, Yang M, Peterfreund GL, Tsou AM, Selamoglu N, Daldal F, Zhong Z, Kan B, Zhu J.  2011.  Vibrio cholerae anaerobic induction of virulence gene expression is controlled by thiol-based switches of virulence regulator AphB.. Proc Natl Acad Sci U S A. 108(2):810-5.

Mourao-Sa D, Roy S, J Blander M.  2013.  Vita-PAMPs: signatures of microbial viability.. Adv Exp Med Biol. 785:1-8.

Venturelli OS, Wang HH, Estrela S, Huang KCasey, Ledesma-Amaro R, Fedorec AJH, Stecher B, Lawson CE, Zarrinpar A, Guo C-J et al..  2023.  What is the key challenge in engineering microbiomes? Cell Syst. 14(2):85-90.

Iliev ID, Lin W-Y, Gaffen SL.  2023.  When IL-17 gets on your nerves.. Cell. 186(3):466-468.

Han S-J, Zaretsky AGlatman, Andrade-Oliveira V, Collins N, Dzutsev A, Shaik J, da Fonseca DMorais, Harrison OJ, Tamoutounour S, Byrd AL et al..  2017.  White Adipose Tissue Is a Reservoir for Memory T Cells and Promotes Protective Memory Responses to Infection.. Immunity. 47(6):1154-1168.e6.

Zhou W, Zhou L, Zhou J, Chu C, Zhang C, Sockolow RE, Eberl G, Sonnenberg GF.  2022.  ZBTB46 defines and regulates ILC3s that protect the intestine.. Nature. 609(7925):159-165.

Moriyama S, Brestoff JR, Flamar A-L, Moeller JB, Klose CSN, Rankin LC, Yudanin NA, Monticelli LA, Putzel GGarbès, Rodewald H-R et al..  2018.  β-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses.. Science. 359(6379):1056-1061.